Phibro Animal Health Corp (NASDAQ:PAHC) CEO Jack Bendheim sold 2,802 shares of Phibro Animal Health stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $38.01, for a total value of $106,504.02. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Phibro Animal Health Corp (PAHC) traded up $0.40 during trading on Monday, reaching $38.75. The company’s stock had a trading volume of 173,555 shares, compared to its average volume of 89,833. The company has a quick ratio of 1.75, a current ratio of 3.12 and a debt-to-equity ratio of 1.82. Phibro Animal Health Corp has a twelve month low of $26.70 and a twelve month high of $40.25. The company has a market capitalization of $1,560.00, a P/E ratio of 22.66, a price-to-earnings-growth ratio of 2.72 and a beta of 1.18.
Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Monday, February 5th. The company reported $0.44 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.38 by $0.06. Phibro Animal Health had a return on equity of 40.49% and a net margin of 7.90%. The business had revenue of $205.90 million for the quarter, compared to the consensus estimate of $194.90 million. During the same period in the previous year, the company posted $0.39 earnings per share. The company’s revenue for the quarter was up 7.5% compared to the same quarter last year. equities analysts expect that Phibro Animal Health Corp will post 1.69 EPS for the current fiscal year.
Several research firms recently weighed in on PAHC. Zacks Investment Research lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, November 1st. BidaskClub upgraded Phibro Animal Health from a “strong sell” rating to a “sell” rating in a research report on Saturday, January 6th. Morgan Stanley lifted their price target on Phibro Animal Health from $30.00 to $36.00 and gave the company an “underweight” rating in a research report on Wednesday, February 7th. Piper Jaffray Companies reissued a “buy” rating and issued a $42.00 target price on shares of Phibro Animal Health in a report on Friday, November 10th. Finally, ValuEngine downgraded Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Thursday, November 9th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $38.20.
Institutional investors have recently added to or reduced their stakes in the business. First Manhattan Co. bought a new stake in Phibro Animal Health in the fourth quarter worth $100,000. Dean Capital Investments Management LLC bought a new position in shares of Phibro Animal Health during the fourth quarter valued at $200,000. Teacher Retirement System of Texas bought a new position in shares of Phibro Animal Health during the fourth quarter valued at $224,000. Crossmark Global Holdings Inc. bought a new position in shares of Phibro Animal Health during the fourth quarter valued at $253,000. Finally, Municipal Employees Retirement System of Michigan lifted its holdings in shares of Phibro Animal Health by 65.9% during the third quarter. Municipal Employees Retirement System of Michigan now owns 7,250 shares of the company’s stock valued at $269,000 after purchasing an additional 2,880 shares in the last quarter. 47.38% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: This piece was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another site, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/3224355/phibro-animal-health-corp-pahc-ceo-sells-106504-02-in-stock.html.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.